NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

醫療保健的人工智慧市場:2020∼2026年

Artificial Intelligence (AI) in Healthcare Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 1008103
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
醫療保健的人工智慧市場:2020∼2026年 Artificial Intelligence (AI) in Healthcare Market 2020-2026
出版日期: 2021年05月04日內容資訊: 英文
簡介

在預測期內,全球醫療保健人工智能 (AI) 市場規模預計將以約 51.5% 的複合年增長率增長。人工智能是一種結合機器學習和深度學習技術力量的技術,應用於遙感、醫療診斷、電子貿易、交通和教育等諸多領域。它是醫療保健行業必不可少的工具之一,因為它使用軟體和算法來支持對複雜醫療數據的分析。基於人工智能的技術也支持檢測和預防患者疾病。促進市場增長的因素包括隨著人們越來越意識到自己的健康,對疾病的早期和有效檢測的需求不斷增加。因此,先進的人工智能技術支持疾病的早期檢測。另一個因素是增加對醫療保健的投資,以為患者提供更好的醫療保健設施,從而減少大手術的成本和時間。

本報告提供醫療保健的人工智慧市場相關調查,提供市場概要,以及各產品類型,各用途,各終端用戶,各地區的趨勢,及加入此市場的主要企業的簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢
  • 規則

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
  • 主要的策略分析
  • Covid19對主要企業的影響

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 醫療保健的人工智慧市場,各產品類型
    • 硬體設備
    • 軟體與服務
  • 醫療保健的人工智慧市場,各用途
    • 診斷
    • 生物標記
    • 活用AI的醫院照護
    • 藥物研發
    • 其他(遠隔監視)
  • 醫療保健的人工智慧市場:各終端用戶
    • 醫院及醫療保健設施
    • 個人保養品
    • 生物科技及製藥企業

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 其他地區

第7章 企業簡介

  • 3Scan, Inc.
  • Atomwise, Inc.
  • Amara Health Analytics Inc.
  • Bay Labs, Inc.
  • BioBeats Inc
  • Cloudmedx inc.
  • Google LLC
  • General Electric Co.
  • IBM Corp.
  • Intel Corp.
  • iCarbonX
  • Johnson & Johnson Services Inc.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • MedAware Systems, Inc.
  • Microsoft Corp.
  • Micron Technology Inc.
  • NVIDIA Corp.
  • Oncora Medical
  • Siemens AG
目錄
Product Code: OMR2023396

Global Artificial Intelligence (AI) in Healthcare Market Size, Share & Trends Analysis Report by Product Type (Hardware and Software & Service), By Application (Diagnosis, Biomarkers, Virtual nursing assistance, Drug Discovery and Others) and By End-User (Hospitals & healthcare facilities, Personal care, and Biotechnology, & pharmaceutical companies) Forecast 2020-2026

The global market for AI in healthcare is projected to have a CAGR of around 51.5% during the forecast period. AI is the technology that combines the power of machine learning and deep learning technology used by many sectors including remote sensing, medical diagnosis, electronic trading, transportation, education, and others. It is one of the essential tools in the healthcare industry as it supports analyzing complex medical data by utilizing software and algorithms. The AI-based technologies are also supported in detecting and preventing diseases in patients. Some of the factors attributing to the growth of the market include increasing demand for early and effective detection of diseases as people are becoming conscious regarding their health. Therefore, advanced AI technology supports in detecting the diagnosis of diseases on an early basis. Another factor being an increasing investment in healthcare to provide better healthcare facilities to patients that result in cost and time reduction of major surgeries.

However, some factors are hindering the growth of the market that includes security concerns with technology as all the data is stored in a wide area network called IoT where leakage of information can take place along with loss of services. Additionally, there must be the availability of relevant data in order to make AI work and without such proper data it's impossible to make them work is another restraint for the market. Since there is a substantial increase in government funding, investment in R&D and venture capital is creating significant opportunities for the growth of the market.

Impact of COVID-19 on AI in Healthcare Industry

The COVID-19 has accelerated the adoption of AI in the healthcare sector, where AI-based solutions can be deployed at scale and respond more quickly to the dynamic nature of such crisis. Many market players universities, established companies, and start-ups are collaborating for the integration of AI in healthcare industry. For Instance, Current Health the UK-based remote monitoring company are supporting Mayo clinic and Baptist Health with their COVID-19 responses by contributing to the industry by high-speed digital adoption and scaling faster to meet demand during such crisis. The companies such as Google, Microsoft, Apple are also involved in initiatives including contact tracing, drug development, remote communications between patients and clinicians among others. COVID-19 has encouraged unparalleled data sharing and collaboration efforts, for instance, C3 AI has created a data lake accessible through APIs that contain a growing number of COVID-19 related data sets including genomic sequences of virus samples and image data. These initiatives will be establishing new infrastructures that will be driving the future growth of AI in healthcare industry.

Segmental Outlook

The global AI in healthcare market is segmented based on product type, application, and end-user. Based on the product type, the market is further classified into hardware and software & services. Further, based on the application the market is classified into diagnosis, biomarkers, AI-enabled hospital care, drug discovery and others. Based on end-user the market is segmented into hospitals and healthcare facilities, personal care, biotechnology, and pharmaceutical companies.

Global AI in Healthcare Market Share by Application, 2020(%)

Source: OMR Global

The AI-enabled Hospital care segment is projected to dominate the global AI in the healthcare market.

Among application, the AI-enabled hospital care segment is estimated to hold the major share in the global AI in healthcare market. AI can act as a care provider in hospitals by using a range of advanced solutions such as smart monitoring of IV solutions, patient alert systems, patient medication tracking, nursing staff assessment systems, and tracking of patient movement within hospitals, among others. Robot-assisted surgeries and a range of applications of AI in routine phlebotomy procedures are some other potential applications of AI in hospitals. It considerably decreases errors in medicinal dosage and further increases the productivity of staff nurses in hospitals.

Regional Outlook

Geographically, the global AI in the healthcare market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Europe is projected to grow at a significant CAGR during the forecast period. The market growth is attributed to the rising number of start-ups, increasing healthcare expenditure in the region. The other factors such well-developed ICT infrastructure, healthcare, and business services in countries such as the UK Germany, and others.

Global AI in Healthcare Market Growth, by Region 2021-2027

Source: OMR Global

North America to hold a considerable share in the global AI in Healthcare market

Geographically, North America is projected to hold a significant market share in the global AI in the healthcare market. The factors that are contributing to the growth of the market include high healthcare expenditures and the presence of major market players in the region such as Google, IBM, GE Healthcare, Jonson & Johnson, and others. Other factors being the rise in demand for digital health systems and decreasing healthcare workforce in various North American countries is raising demand for effective diagnosis and treatment services. US and Canada are the major economies of North America that have well-developed IT infrastructure and employ a large number of connected devices in healthcare facilities.

Market Players Outlook

The key players in the AI in the healthcare market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market include Siemens AG, Microsoft Corp., IBM Corp., Google, LLC., and General Electric Co., among others. These market players adopt various strategies such as product launches, partnerships, collaborations, mergers, and acquisitions to sustain a strong position in the market. In February 2019, IBM Corp. announced that it plans to make a 10-year $50 million investment in research collaborations with two academic centers Brigham and Women's capital and Vanderbilt University Medical Center to advance AI research and its applications in major public health issues. This scientific collaboration with both the universities will be focusing upon critical health issues that are well suited to AI solutions.

The Report Covers

Market value data analysis of 2019 and forecast to 2026.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global AI in the Healthcare market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global AI in Healthcare Industry
  • Recovery Scenario of Global AI in Healthcare Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segment
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of Covid on key players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global AI in Healthcare marketbyProduct Type
    • 5.1.1. Hardware
    • 5.1.2. Software and Services
  • 5.2. Global AI in Healthcare market by Application
    • 5.2.1. Diagnosis
    • 5.2.2. Biomarkers
    • 5.2.3. AI Enabled Hospital Care
    • 5.2.4. Drug Discovery
    • 5.2.5. Others (Remote Monitoring)
  • 5.3. Global AI in Healthcare market by End-user
    • 5.3.1. Hospitals and Healthcare Facilities
    • 5.3.2. Personal Care
    • 5.3.3. Biotechnology and Pharmaceutical Companies

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 3Scan, Inc.
  • 7.2. Atomwise, Inc.
  • 7.3. Amara Health Analytics Inc.
  • 7.4. Bay Labs, Inc.
  • 7.5. BioBeats Inc
  • 7.6. Cloudmedx inc.
  • 7.7. Google LLC
  • 7.8. General Electric Co.
  • 7.9. IBM Corp.
  • 7.10. Intel Corp.
  • 7.11. iCarbonX
  • 7.12. Johnson & Johnson Services Inc.
  • 7.13. Koninklijke Philips N.V.
  • 7.14. Medtronic PLC
  • 7.15. MedAware Systems, Inc.
  • 7.16. Microsoft Corp.
  • 7.17. Micron Technology Inc.
  • 7.18. NVIDIA Corp.
  • 7.19. Oncora Medical
  • 7.20. Siemens AG

LIST OF TABLES

  • 1. GLOBAL AI IN HEALTHCAREMARKETRESEARCH AND ANALYSIS BY PRODUCT TYPE,2020-2027 ($ MILLION)
  • 2. GLOBALAI IN HEALTHCARE HARDWAREMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 3. GLOBALAI IN HEALTHCARESOFTWARE & SERVICESMARKETRESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 4. GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 5. GLOBALAI IN HEALTHCARE FORDIAGNOSISMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBALAI IN HEALTHCARE FORBIOMARKERSMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBALAI IN HEALTHCARE FORAI ENABLED HOSPITAL CAREMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL AI IN HEALTHCARE FORDRUG DISCIVERYMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL AI IN HEALTHCARE FOROTHER APPLICATIONMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 11. GLOBAL AI IN HEALTHCARE FOR HOSPITALS AND HEALTHCARE FACILITIESMARKET RESEARCH AND ANALYSIS BY REGION 2020-2027 ($ MILLION)
  • 12. GLOBAL AI IN HEALTHCARE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIESMARKET RESEARCH AND ANALYSIS BY REGION 2020-2027 ($ MILLION)
  • 13. GLOBAL AI IN HEALTHCARE FOR PERSONAL CAREMARKET RESEARCH AND ANALYSIS BY REGION 2020-2027 ($ MILLION)
  • 14. GLOBALAI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICAN AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 16. NORTH AMERICAN AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE,2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 19. EUROPEAN AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. EUROPEAN AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE,2020-2027 ($ MILLION)
  • 21. EUROPEAN AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 22. EUROPEAN AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 24. ASIA-PACIFIC AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE,2020-2027 ($ MILLION)
  • 25. ASIA-PACIFIC AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 26. ASIA-PACIFIC AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 27. REST OF THE WORLD AI IN HEALTHCAREMARKE TRESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 28. REST OF THE WORLD AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE,2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 30. REST OF THE WORLD AI IN HEALTHCAREMARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

1. IMPACT OF COVID-19 ON GLOBAL AI IN HEALTHCAREMARKET, 2020-2027 (% MILLION)

2. IMPACT OF COVID-19 ON GLOBAL AI IN HEALTHCAREMARKET BY SEGMENT, 2020-2027 (% MILLION)

  • 3. RECOVERY OF GLOBAL AI IN HEALTHCAREMARKET, 2020-2027 (%)
  • 4. GLOBAL AI IN HEALTHCAREMARKETSHARE BY PRODUCT TYPE,2020 VS 2027 (%)
  • 5. GLOBAL AI IN HEALTHCAREMARKETSHARE BYAPPLICATION, 2020 VS 2027 (%)
  • 6. GLOBAL AI IN HEALTHCAREMARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 7. GLOBAL AI IN HEALTHCAREMARKETSHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBALAI IN HEALTHCAREHARDWAREMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBALAI IN HEALTHCARE SOFTWARE ANDSERVICE MARKETSHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 10. GLOBAL AI IN HEALTHCARE FORDIAGNOSISMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 11. GLOBALAI IN HEALTHCARE FORBIOMARKERS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 12. GLOBALAI IN HEALTHCARE FORAI ENABLED HOSPITAL CAREMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 13. GLOBAL AI IN HEALTHCARE FORDRUG DISCOVERYMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 14. GLOBAL AI IN HEALTHCARE FOROTHER APPLICATIONMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 15. GLOBALAI IN HEALTHCAREFOR HOSPITALS AND HEALTHCARE FACILITIESMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 16. GLOBALAI IN HEALTHCARE FORPERSONAL CAREMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 17. GLOBALAI IN HEALTHCARE FORBIOTECHNOLOGY AND PHARMACEUTICAL COMPANIESMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 18. US AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 19. CANADA AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 20. UK AI IN HEALTHCAREMARKET SIZE, 2020-2027($ MILLION)
  • 21. FRANCE AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 22. GERMANY AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 23. ITALY AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 24. SPAIN AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 25. REST OF EUROPE AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 26. INDIA AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 27. CHINA AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 28. JAPAN AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 29. SOUTH KOREA AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 30. REST OF ASIA-PACIFIC AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)
  • 31. REST OF THE WORLD AI IN HEALTHCAREMARKETSIZE, 2020-2027($ MILLION)